<scp>EMB</scp> ‐01, a Tetravalent Bispecific Antibody, Inducing Co‐Degradation of <scp>EGFR</scp> and c‐Met for Enhanced Anti‐Tumor Efficacy
Cited by 0
Related Papers
Augmented antitumor activity by olaparib plus AZD1775 in gastric cancer through disrupting DNA damage repair pathways and DNA damage checkpoint
|Journal of Experimental & Clinical Cancer Research|2018|56
Characterization and validation of potential therapeutic targets based on the molecular signature of patient-derived xenografts in gastric cancer
|Journal of Hematology & Oncology|2018|44
CLDN18.2 and 4-1BB bispecific antibody givastomig exerts antitumor activity through CLDN18.2-expressing tumor-directed T-cell activation
|Journal for ImmunoTherapy of Cancer|2023|39
From AVATAR Mice to Patients: RC48-ADC Exerted Promising Efficacy in Advanced Gastric Cancer With HER2 Expression
|Frontiers in Pharmacology|2022|25
Polo‐like kinase 1 inhibitor NMS‐P937 represses nasopharyngeal carcinoma progression via induction of mitotic abnormalities
|Journal of Biochemical and Molecular Toxicology|2023|2